Core Points - A shareholder class action lawsuit has been filed against Molina Healthcare, Inc. alleging materially false and misleading statements regarding the company's business and operations [1] - The lawsuit claims that Molina's financial guidance for fiscal year 2025 is likely to be cut due to adverse facts concerning medical cost trend assumptions and a dislocation between premium rates and medical costs [1] - The lawsuit highlights that Molina's near-term growth is dependent on a lack of utilization of behavioral health, pharmacy, and inpatient and outpatient services [1] Legal Information - Shareholders who purchased Molina shares between February 5, 2025, and July 23, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request to be appointed lead plaintiff in the case is December 2, 2025 [3] - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of recovering funds for shareholders affected by corporate misconduct [3]

Core Viewpoint - The Molina Healthcare class action lawsuit alleges that the company and its executives violated the Securities Exchange Act of 1934 by failing to disclose critical information regarding financial performance and medical cost trends during the specified class period [1][3]. Group 1: Lawsuit Details - The class action lawsuit seeks to represent purchasers or acquirers of Molina Healthcare securities from February 5, 2025, to July 23, 2025 [1]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.) [1]. - Allegations include failure to disclose adverse facts about medical cost trend assumptions and a dislocation between premium rates and medical costs [3]. Group 2: Financial Performance - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% at the midpoint, citing ongoing medical cost pressures [4]. - On July 23, 2025, Molina Healthcare reported GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year over year, and revised its full-year 2025 adjusted earnings expectation to no less than $19.00 per diluted share [5]. Group 3: Market Reaction - Following the earnings report on July 7, 2025, Molina Healthcare's stock price fell significantly, reflecting investor concerns over the disclosed medical cost pressures [4]. - After the July 23, 2025 report, the stock price dropped nearly 17%, indicating a strong negative market reaction to the revised earnings guidance [5].

Core Viewpoint - A class action lawsuit has been filed against Molina Healthcare, Inc. in the United States District Court for the Central District of California, involving securities purchased between February 5, 2025, and July 23, 2025 [1] Group 1 - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., and is registered under Case No. 2:25-cv-09461 [1] - The lawsuit represents individuals and entities that acquired Molina Healthcare, Inc. securities during the specified Class Period [1]

Company Overview - Molina Healthcare, Inc. (MOH) is a managed care company providing health insurance and related services primarily through government-sponsored programs such as Medicaid, Medicare, and state health insurance exchanges, with a market capitalization of approximately $10.4 billion [1] Earnings Expectations - For fiscal Q3 2025, analysts anticipate a profit of $3.97 per share, representing a 33.9% decline from $6.01 per share in the same quarter last year [2] - For the full fiscal year 2025, the expected profit is $18.87 per share, down 16.7% from $22.65 in fiscal 2024, but projected to grow 4% year-over-year to $19.63 in fiscal 2026 [3] Stock Performance - MOH stock has decreased by 41.5% over the past 52 weeks, underperforming the SPDR S&P Health Care Services ETF's 7% gains and the S&P 500 Index's 17.6% increase during the same period [4] Margin Pressures - The decline in stock price is attributed to rising medical costs across its Medicaid, Medicare, and Affordable Care Act (ACA) businesses, which are squeezing margins, leading the company to cut its full-year earnings guidance [5] Regulatory Risks - There is significant regulatory and policy uncertainty, particularly regarding Medicaid funding, ACA subsidies, and changes to health insurance programs, which adds additional risk for investors [6] Analyst Ratings - The overall rating for MOH stock is "Hold," a downgrade from the previous "Moderate Buy" rating three months ago, with 17 analysts covering the stock: four recommend "Strong Buy," 11 advise "Hold," one suggests "Moderate Sell," and one gives a "Strong Sell" rating [7] - The stock is currently trading above its mean price target of $189.43, with a Street-high price target of $228 indicating a 17.4% premium to current price levels [7]

Follower of the markets. My investment style is mostly looking for asymmetrical risk/reward opportunities on the long and short side. I utilize a mixture of stock and derivatives positions in my investment approach. The time horizon of my investments varies.For some more investment insights or if you want to message me, feel free to do so.Analyst’s Disclosure:I/we have a beneficial long position in the shares of MOH either through stock ownership, options, or other derivatives. I wrote this article myself, ...

Follower of the markets. My investment style is mostly looking for asymmetrical risk/reward opportunities on the long and short side. I utilize a mixture of stock and derivatives positions in my investment approach. The time horizon of my investments varies.For some more investment insights or if you want to message me, feel free to do so.Analyst’s Disclosure:I/we have a beneficial long position in the shares of MOH either through stock ownership, options, or other derivatives. I wrote this article myself, ...

Vancouver, British Columbia – TheNewswire - October 1, 2025 – Plaid Technologies Inc. (CSE: STIF) (OTC: STIFF) (FRA: 5QX0) (“Plaid” or the “Company”) today announces that, due to the ongoing Canada Post labour strike, which began on September 25, 2025 (the “Postal Strike”), the management information circular (the “Circular”), form of proxy and related meeting materials (collectively, the “Meeting Materials”) for the Company’s upcoming annual general and special meeting of shareholders, to be held on Octobe ...

Air Canada is betting on free beer and wine at the back of the plane to help fill more seats, an executive said on Wednesday, as North American airlines face passenger pushback over fees for extra bag... ...

Core Insights - The U.S. healthcare sector is facing challenges from rising medical costs, regulatory scrutiny, and changing patient behavior, impacting health insurers' margins [1] - UnitedHealth Group and Molina Healthcare are highlighted for their adaptability in this turbulent environment [1] Company Overview - UnitedHealth is the largest U.S. insurer with a market cap of $313 billion, offering a diversified model that includes a health services arm, Optum [4] - Molina focuses primarily on Medicaid and government programs, serving over 5.7 million members [8] Financial Performance - UnitedHealth reported revenues of $111.6 billion, a 12.9% year-over-year increase, with Optum contributing $67.2 billion, a 6.8% increase [5] - Molina's revenues reached $11.4 billion, up 15.7% year-over-year, driven by Marketplace membership growth [9] Profitability Metrics - UnitedHealth's adjusted net margin was 3.3%, outperforming Molina's 2.6% [6] - Molina's medical care ratio (MCR) rose to 90.4%, higher than UnitedHealth's 89.4%, indicating pressure on Molina's earnings [9][10] Growth Strategies - UnitedHealth is focused on long-term growth through technology investments and expanded provider services [7] - Molina is attempting to diversify its offerings, particularly in Medicare and Marketplace plans, but remains heavily reliant on Medicaid [11] Valuation Comparison - Molina trades at 9.81X forward earnings, while UnitedHealth trades at 20.19X, indicating a premium for UnitedHealth [14] Price Performance - Year-to-date, UnitedHealth shares are down 31.7%, while Molina has declined 35%, compared to a 25% slump in the broader industry [15] Analyst Expectations - Zacks Consensus Estimates for UnitedHealth's EPS in 2025 and 2026 are $16.21 and $17.51, reflecting a 41.4% decline followed by 8.1% growth [13] - For Molina, the estimates are $18.56 and $19.57, signaling an 18.1% drop and 5.4% growth, respectively [13] Conclusion - UnitedHealth's scale, profitability, and diversification through Optum position it as a stronger candidate for recovery compared to Molina, which faces more funding pressures and thinner margins [20]

Group 1 - Centene Corporation's stock has rebounded significantly, rising 6% on September 24 and nearly 20% over the last month after a period of underperformance [2] - The stock's recent rally suggests it may have been undervalued, attracting investors who were waiting for a pullback [3] - Molina Healthcare appears to be a more attractive investment opportunity compared to Centene, demonstrating stronger revenue growth and profitability [3][6] Group 2 - Molina Healthcare's revenue growth over the last 12 months was 16.1%, while Centene's was 13.0% [6] - Over the last three years, Molina's average revenue growth was 12.8%, surpassing Centene's 8.9% [6] - Molina Healthcare has a last twelve months (LTM) margin of 3.8% and a three-year average margin of 4.2%, outperforming Centene in profitability [6] Group 3 - Centene provides health plan coverage and services to under-insured and uninsured individuals through government programs and commercial healthcare products [4] - Molina Healthcare offers managed healthcare services to low-income families and individuals, catering to 5.2 million members across 18 states [4]